Table 1 Patient characteristics. Abbreviations are listed in the respective section of the manuscript
From: 18F-FDG-PET-MRI for the assessment of acute intestinal graft-versus-host-disease (GvHD)
Characteristic | n | Percentage | Characteristic | n | Percentage |
|---|---|---|---|---|---|
Number of patients | 21 | ATG | |||
Gender | no | 7 | 33.3 | ||
Female | 12 | 57.1 | yes | 14 | 66.7 |
Male | 9 | 42.9 | conditioning | ||
Age | reduced dose | 9 | 42.9 | ||
median: 60 | range: 33–71 | sequential | 3 | 14.3 | |
Diagnosis | myeloablative | 0 | 0.0 | ||
AML | 7 | 33.3 | others | 9 | 42.9 |
ALL | 1 | 4.8 | immunosuppression | ||
CML | 1 | 4.8 | CSA/MTX | 10 | 47.6 |
CLL | 0 | 0.0 | CSA/MMF | 11 | 52.4 |
MDS | 5 | 23.8 | other | 0 | 0.0 |
MPS | 1 | 4.8 | clinical stage | ||
MM | 1 | 4.8 | 0 (< 500) | 2 | 9.5 |
B-NHL | 2 | 9.5 | II(500–1000) | 8 | 38.1 |
T-NHL | 3 | 14.3 | II(1000–1500) | 6 | 28.6 |
Match | III (> 1500) | 5 | 23.8 | ||
MRD | 8 | 38.1 | IV (blood) | 0 | 0.0 |
MUD | 9 | 47.6 | Clinical grade | ||
MMUD | 3 | 14.3 | Grade I | 2 | 9.5 |
HAPLO | 0 | 0.0 | Grade II | 8 | 38.1 |
TBI | Grade III | 10 | 47.6 | ||
no | 18 | 85.7 | Grade IV | 1 | 4.8 |
4 Gy | 1 | 4.8 | steroids at date PET | ||
8 Gy | 2 | 9.5 | yes | 14 | 66.7 |
12 Gy | 0 | 0.0 | no | 7 | 33.3 |